Physical performance and associated electrolyte changes after haemoglobin normalization: A comparative study in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 14, Issue 5, 1999, Pages 1182-1187

  McMahon, Lawrence P ^a   McKenna, Michael J ^b   Sangkabutra, Termboon ^c   Mason, Kim ^a   Sostaric, Simon ^b   Skinner, Sandford L ^c   Burge, Caroline ^c   Murphy, Brendan ^a   Crankshaw, David ^c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b VICTORIA UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Epoetin; Exercise; Haemodialysis; Normal haemoglobin; Potassium

Indexed keywords

HEMOGLOBIN; LACTIC ACID; POTASSIUM ION;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROLYTE BALANCE; EXERCISE; HEMODIALYSIS; HUMAN; LACTATE BLOOD LEVEL; PHYSICAL PERFORMANCE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANEMIA; BLOOD VOLUME; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPOETIN ALFA; EXERCISE; EXERCISE TEST; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PLASMA VOLUME; POTASSIUM; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 0032943189     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.5.1182     Document Type: Article

References (41)

1. Mayer G, Thum J, Cada EM, Stummvoll HK, Graf H. Working capacity is increased following treatment with recombinant human erythropoietin. Kidney Int 1988; 34: 525-528
2. McMahon LP, Johns JA, McKenzie A, Austin M, Fowler R, Dawborn JK. Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietin. Nephrol Dial Transplant 1992; 7: 1199-1206
3. Bárány P, Freyschuss U, Pettersson E, Bergstrom J. Treatment of anaemia in haemodialysis patients with erythropoietin: long term effects on exercise capacity. Clin Sci 1993; 84: 441-447
4. Lewis NP, Macdougall I, Willis N, Coles GA, Williams JD, Henderson AH. Effects of the correction of renal anaemia by erythropoietin on physiological changes during exercise. Eur J Clin Invest 1993; 23: 423-427
5. Marrades RM, Alonso J, Roca J, et al. Cellular bioenergetics after erythropoietin therapy in chronic renal failure. J Clin Invest 1996; 97: 2101-2110
6. Macdougall IC, Lewis NP, Saunders MJ, et al. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. Lancet 1990; 335: 489-493
7. Moore GE, Parsons DB, Stray-Gunderson J, et al. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis 1993; 22: 277-287
8. Diesel W, Noakes TD, Swanepoel C, Lambert M. Isokinetic muscle strength predicts maximum exercise tolerance in renal patients on chronic haemodialysis. Am J Kidney Dis 1990; XVI: 109-114
9. Rogerson ME, Rylance PB, Wilson, et al. Carnitine and weakness in haemodialysis patients. Nephrol Dial Transplant 1989; 4: 366-371
10. Grunze M, Kohlmann M, Mulligan M, Grüner I, Koeppel M, Bommer J. Mechanisms of improved physical performance of chronic hemodialysis patients after erythropoietin treatment. Am J Nephrol 1990; 10 (Suppl 2): 15-23
11. Thompson CH, Kemp GJ, Taylor DJ, Ledingham JGG, Radda GK, Rajagopalan B. Effect of chronic uraemia on skeletal muscle metabolism in man. Nephrol Dial Transplant 1993; 8: 218-222
12. 31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients. J Clin Invest 1993; 91: 420-424
13. Clark BA, Shannon C, Brown RS, Gervino EV. Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease. J Am Soc Nephrol 1996; 7: 1223-1227
14. +-pump during exercise. In: Hargreaves M, Thompson MW (eds) Biochemistry of Excercise X. Human Kinetics, Champaigne, IL, 1998, 71-97
15. Sjøgaard G. Role of exercise-induced potassium fluxes underlying muscle fatigue: a brief review. Can J Physiol Pharmacol 1991; 69: 238-245
16. Cole CH. Decreased ouabain-sensitive adenosine triphosphatase activity in the erythrocyte membrane of patients with chronic renal disease. Clin Sci 1973; 45: 775-784
17. Druml W, Kelly RA, May RC, Mitch WE. Abnormal cation transport in uraemia. Mechanisms in adipocytes and skeletal muscle from uraemic rats. J Clin Invest 1988; 81: 1197-1203
18. Bonilla S, Goecke IA, Bozzo S, Alvo M, Michea L, Marusic ET. Effect of chronic renal failure on Na, K-ATPase alpha 1 and alpha 2 mRNA transcription in rat skeletal muscle. J Clin Invest 1991; 88: 2137-2141
19. Goecke IA, Bonilla S, Marusic ET, Alvo M. Enhanced insulin sensitivity in extrarenal potassium handling in uraemic rats. Kidney Int 1991; 39: 39-43
20. Wald M, Gutnisky A, Borda E, Sterin-Borda L. Erythropoietin modified the cardiac action of ouabain in chronically anaemic-uraemic rats. Nephron 1995; 71: 190-196
21. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131: 700-708
22. Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of Exercise Tenting and Interpretation, Chapter 6, Normal Values. Lea and Febiger, Philadelphia, PA, 1987; 30-32
23. Burge CM, Skinner SL. Determination of hemoglobin mass and blood volume with CO: evaluation and application of a method. J Appl Physiol 1995; 79: 623-631
24. McKenna MJ, Heigenhauser GJ, McKelvie RS, MacDougall DJ, Norman JL. Sprint training enhances ionic regulation during intense exercise in men. J Physiol 1997; 501: 687-702
25. Besarab A, Bolton WK. Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
26. Woodson R. Hemoglobin concentration and exercise capacity. Am Rev Respir Dis 1984; 129 (Suppl): S72-S75
27. Robertson HT, Haley NR, Guthrie M, Cardenas D, Eschbach JW, Adamson JW. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kid Dis 1990; XV: 325-332
28. Kettner-Melsheimer A, Weiß M, Huber W. Physical work capacity in chronic renal disease. Int J Artif Organs 1987; 10: 23-30
29. Fahal IH, Bell GM, Bone JM, Edwards RHT. Physiological abnormalities of skeletal muscle in dialysis patients. Nephrol Dial Transplant 1997; 12; 119-127
30. Davenport A, King RFGJ, Ironside JW, Will EJ, Davison AM. The effect of treatment with recombinant human erythropoietin on the histological appearance and glycogen content of skeletal muscle in patients with chronic renal failure treated by regular hospital haemodialysis. Nephron 1993; 64: 89-94
31. Clyne N, Esbjörnson M, Jogestrand T, Lins L-E, Pehrsson SK. Effects of renal failure on skeletal muscle. Nephron 1993; 63: 395-399
32. Thompson CH, Kemp GJ, Taylor DJ, Ledingham JG, Radda GK, Rajagopalan B. Effect of chronic uraemia on skeletal muscle metabolism in man. Nephrol Dial Transplant 1993; 8: 218-222
33. Thompson CH, Kemp GJ, Taylor DJ, Radda GK. Bioenergetic effects of erythropoietin in skeletal muscle [letter]. Nephron 1996; 74: 239-240
34. Conjard A, Ferrier B, Martin M, Cailette A, Carrier H, Bavarel G. Effects of chronic renal failure on enzymes of energy metabolism in individual human muscle fibres. J Am Soc Nephrol 1995; 6: 68-74
35. Goldberg AP, Geltman EM, Hagberg JM, et al. Therapeutic effects of exercise training for haemodialysis patients. Kidney Int 1983; 24 (Suppl 16): S303-S309
36. McKenna MJ. The roles of ionic processes in muscular fatigue during intense exercise. Sports Med 1992; 13: 134-145
37. +-pump and muscle excitability. Acta Physiol Scand 1998; 162: 183-190
38. Huber W, Marquet E. Plasma potassium and blood pH following physical exercise in dialysis patients. Nephron 1985; 40: 383-384
39. +-ATPase alpha 1 and alpha 2 mRNA transcription in rat skeletal muscle. J Clin Invest 1991; 88: 2137-2141
40. Renaud JM, Gramolini A, Light P, Comtois A. Modulation of muscle contractility during fatigue and recovery by ATP sensitive potassium channel. Acta Physiol Scand 1996; 156: 203-212
41. + transport. Acta Physiol Scand 1996; 156: 247-256